adMare Bioinnovations Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 68

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $92M

  • Investors
  • 1

adMare Bioinnovations General Information

Description

Operator of a life sciences innovation hub intended to build companies, ecosystems, and industry-ready talent. The company's services include sourcing therapeutically promising research from academic and biotech partners to create new companies, providing specialized expertise, infrastructure, and capital to help existing companies scale up, and driving the growth of those companies by training qualified personnel, enabling biotechnology startups to further develop their product pipelines and advance their business to the next inflection point.

Contact Information

Formerly Known As
CDRD, NEOMED Institute
Ownership Status
Privately Held (backing)
Financing Status
Corporation
Corporate Office
  • UBC Innovation Centre
  • 2405 Wesbrook Mall, 4th Floor
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Education and Training Services (B2B)
Vertical(s)
Corporate Office
  • UBC Innovation Centre
  • 2405 Wesbrook Mall, 4th Floor
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

adMare Bioinnovations Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 30-Mar-2022 $92M Completed Generating Revenue
1. Merger of Equals 30-May-2019 Completed Generating Revenue
To view adMare Bioinnovations’s complete valuation and funding history, request access »

adMare Bioinnovations Patents

adMare Bioinnovations Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020207426-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-(4-(1-cyano-1-methylethyl)phenyl)ethyl}acetamide Inactive 08-Jan-2019
CA-3125655-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Pending 08-Jan-2019
EP-3908574-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Inactive 08-Jan-2019
EP-3908574-A4 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Inactive 08-Jan-2019
WO-2020142842-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Inactive 08-Jan-2019 C07D235/16
To view adMare Bioinnovations’s complete patent history, request access »

adMare Bioinnovations Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

adMare Bioinnovations Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Government of Canada Limited Partner
To view adMare Bioinnovations’s complete investors history, request access »

adMare Bioinnovations Investments & Acquisitions (34)

adMare Bioinnovations’s most recent deal was a Later Stage VC with Thryv Therapeutics for . The deal was made on 03-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Thryv Therapeutics 03-Nov-2026 Later Stage VC Drug Discovery
Specific Biologics 02-Nov-2026 Later Stage VC Other Healthcare Technology Systems
Kainova Therapeutics 10-Feb-2026 Later Stage VC Drug Discovery
Ocythera 27-Jan-2026 Seed Round Biotechnology
Find Therapeutics 09-Jan-2026 Later Stage VC Drug Discovery
You’re viewing 5 of 34 investments and acquisitions. Get the full list »

adMare Bioinnovations FAQs

  • When was adMare Bioinnovations founded?

    adMare Bioinnovations was founded in 2019.

  • Where is adMare Bioinnovations headquartered?

    adMare Bioinnovations is headquartered in Vancouver, Canada.

  • What is the size of adMare Bioinnovations?

    adMare Bioinnovations has 68 total employees.

  • What industry is adMare Bioinnovations in?

    adMare Bioinnovations’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is adMare Bioinnovations a private or public company?

    adMare Bioinnovations is a Private company.

  • What is adMare Bioinnovations’s current revenue?

    The current revenue for adMare Bioinnovations is .

  • Who are adMare Bioinnovations’s investors?

    Government of Canada has invested in adMare Bioinnovations.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process